Michael Grant, MD
Assistant Professor of Medicine (Medical Oncology)Cards
About
Research
Overview
Medical Research Interests
Clinical Care
Overview
Michael Grant, MD, is a medical oncologist and hematologist who cares for patients affected by cancer and other hematologic conditions, focusing on thoracic and genitourinary malignancies.
“I was inspired to become a doctor because I like people,” Dr. Grant says. “It is a unique privilege to be able to help people at a potentially vulnerable time, when they are facing challenges they may have never faced before. Medical oncology and hematology are two disciplines in which forming interpersonal relationships and building trust are vital.”
The field of oncology is advancing constantly, making it crucial for physicians to keep their practice up to standard, Dr. Grant says, and this has helped shaped his own approach. “I am passionate about personalized care, leveraging molecular features of a patient's cancer to choose the best treatment for that individual. This involves comprehensively testing for all available ‘biomarkers’ so that each treatment decision is maximally informed. In order to fulfill this commitment, I conduct research, build connections with other experts, and work diligently keep up with the latest advances in the field.”
An assistant professor of medical oncology at Yale School of Medicine, Dr. Grant’s research interests include targeted and immunotherapy approaches to the treatment of non-small cell lung cancer.
Clinical Specialties
Fact Sheets
Small Cell Lung Cancer
Learn More on Yale MedicineNon-Small Cell Lung Cancer
Learn More on Yale MedicineUrologic Cancers
Learn More on Yale MedicineLung Cancer
Learn More on Yale Medicine
Board Certifications
Medical Oncology
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2023
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Original Certification Date
- 2019
Yale Medicine News
News & Links
News
- November 14, 2024
Understanding Lung Cancer: A Conference to Raise Awareness and Offer Hope to Those Impacted by Lung Cancer
- December 13, 2022Source: ASCO Daily News
Emerging Treatment Options in the Management of Resistance to Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer
- December 04, 2022
Why Some Lung Tumors Respond Better to Targeted Therapies Than Others
- September 07, 2022
Smilow Cancer Hospital in Waterbury Welcomes Dr. Michael Grant